ArticleBritish journal of cancer2024

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Anxo Rio-Vilariño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.